FDA CLEARS OSSEUS’ CERVICAL IMPLANT (Orthopedics This Week)
website - http://www.osseus.com/
On July 3, 2017, the FDA cleared Osseus Corporation’s new cervical interbody hybrid composition implant which incorporates rough, porous titanium with the radiolucent and biomechanical properties of PEEK. The newly commercialized implant is indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease at one or two contiguous levels within the cervical spine.
Eric Hansen, chief executive officer of Osseus, commented to OTW, “During the building days of Osseus Fusion Systems, we had to bootstrap our way up as a self-funded, no venture-capital organization that consists of myself and my partner, Robert Pace, as well as a lean staff of six, three of which are engineers.”
“We wanted to compete in the 3D-printed and injection-modeled arena like other large companies, but both processes seemed out of range for many reasons. I am proud to say that in this very crowded industry, we have developed a product that is extremely unique. As we gathered our surgeon development team of orthopedic and neurosurgeons, our target was to create a robust...
